dr. V.A.S.H. Dalm

Search results

• 2024

  Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

  Aalbers, A. M., van Daele, P. L. A., Dalm, V. A. S. H., Valk, P. J. M. & Raaijmakers, M. H. G. P., Aug 2024, In: HemaSphere. 8, 8, e129.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

  Open Access

  File
  3 Citations (Scopus)

  7 Downloads (Pure)
• 2023

  Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency

  van Stigt, A. C., Dalm, V. A. S. H., Nagtzaam, N. M. A., van Hagen, P. M., Dik, W. A. & IJspeert, H., Nov 2023, In: Journal of Clinical Immunology. 43, 8, p. 1754-1757 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

  Open Access

  File
  6 Citations (Scopus)

  17 Downloads (Pure)